Results 51 to 60 of about 5,985 (143)

Correction: Receipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in Nigeria. [PDF]

Malar J
Ibinaiye T, Rotimi K, Balogun A, Aidenagbon A, Oguoma C, Rassi C, Baker K, Oresanya O, Nnaji C.   +8 more
europepmc   +2 more sources

Phase one of a hybrid effectiveness-implementation study to assess the feasibility, acceptability and effectiveness of implementing seasonal malaria chemoprevention in Nampula Province, Mozambique. [PDF]

Malar J
Baker K, Pulido Tarquino IA, Aide P, Bonnington C, Rassi C, Richardson S, Nnaji C, Roca-Feltrer A, Rodrigues M, Sitoe M, Enosse S, McGugan C, Saute F, Matambisso G, Candrinho B.   +14 more
europepmc   +2 more sources

Seasonal Malaria Chemoprevention Coverage in Guinea in 2019 [PDF]

, 2020
SMC involves the administration of a treatment course of sulfadoxine-pyrimethamine plus amodiaquine once a month to children aged 3 59 months during the high risk period each year to prevent malaria. SMC over 4 months of the year was introduced in Guinea in 2015 in 6 prefectures, scaling up to 13 prefectures by 2018.
Loua, Kovana Marcel, Milligan, Paul
openaire   +2 more sources

Impact of seasonal malaria chemoprevention on prevalence of malaria infection in malaria indicator surveys in Burkina Faso and Nigeria [PDF]

BMJ Global Health, 2022
Background In 2012, the WHO issued a policy recommendation for the use of seasonal malaria chemoprevention (SMC) to children 3–59 months in areas of highly seasonal malaria transmission. Clinical trials have found SMC to prevent around 75% of clinical malaria.
Monica Anna de Cola, Benoît Sawadogo, Sol Richardson, Taiwo Ibinaiye, Adama Traoré, Cheick Saïd Compaoré, Chibuzo Oguoma, Olusola Oresanya, Gauthier Tougri, Christian Rassi, Arantxa Roca-Feltrer, Patrick Walker, Lucy C Okell   +12 more
openaire   +5 more sources

Evaluation of seasonal malaria chemoprevention implementation in the Upper East region of Northern Ghana. [PDF]

Malar J
Ghana adopted the WHO-recommended Seasonal Malaria Chemoprevention (SMC) in 2016 following a pilot study as a vital strategy for malaria control. SMC is the intermittent administration of a preventive and curative dose of anti-malarial medicine (Sulfadoxine-Pyrimetamine + Amodiaquine) during four months of the malaria season.
Ayamba EY, Dzotsi EK, Dormechele W, Ansah NA, Bangre O, Nyuzaghl JA, Abilba SA, Boakye-Boateng SK, Ansah PO.   +8 more
europepmc   +4 more sources

Epidemiology of malaria in an area of seasonal transmission in Niger and implications for the design of a seasonal malaria chemoprevention strategy [PDF]

Malaria Journal, 2013
Abstract Background Few data are available about malaria epidemiological situation in Niger. However, implementation of new strategies such as vaccination or seasonal treatment of a target population requires the knowledge of baseline epidemiological features of malaria.
Guillebaud, Julia, Mahamadou, Aboubacar, Zamanka, Halima, Katzelma, Mariama, Arzika, Ibrahim, Ibrahim, Maman, Eltahir, Elfatih, Labbo, Rabiou, Druilhe, Pierre, Duchemin, Jean-Bernard, Fandeur, Thierry   +10 more
openaire   +6 more sources

Seasonal malaria chemoprevention for malaria in children in areas with seasonal malaria

, 2022
This report was considered by the WHO/GMP Guideline Development Group on Malaria Chemoprevention for “Section 4.2.3 Seasonal malaria chemoprevention (SMC)” of the WHO Guidelines for malaria, 3 June 2022.
Thwing JI, Williamson J, Cavros I, Bhattarai A, Gutman J   +4 more
openaire   +2 more sources

Knowledge and acceptance of malaria vaccine among parents of under‐five children of malaria endemic areas in Bangladesh: A cross‐sectional study

Health Expectations, Volume 26, Issue 6, Page 2630-2643, December 2023., 2023
Abstract Background Malaria exists as an endemic in many countries including Bangladesh and the malaria vaccine is not yet available here. The study aimed to assess the level of knowledge and acceptance of the malaria vaccination among the parents of children under the age of five in Bangladesh's malaria‐endemic areas and the sociodemographic ...
Mohammad Ashraful Amin, Sadia Afrin, Atia S. Bonna, Md Faisal K. Rozars, Mohammad Hayatun Nabi, Mohammad Delwer H. Hawlader   +5 more
wiley   +1 more source

Review of intervention products for use in the prevention and control of anemia

Annals of the New York Academy of Sciences, Volume 1529, Issue 1, Page 42-60, November 2023., 2023
Abstract Anemia remains a major public health problem, especially in low‐ and middle‐income countries. The World Health Organization recommends several interventions to prevent and manage anemia in vulnerable population groups, including young children, menstruating adolescent girls and women, and pregnant and postpartum women.
Daniel Lopez de Romaña, Alison Mildon, Jenna Golan, Maria Elena D. Jefferds, Lisa M. Rogers, Mandana Arabi   +5 more
wiley   +1 more source

Spatial Optimization Methods for Malaria Risk Mapping in Sub‐Saharan African Cities Using Demographic and Health Surveys

GeoHealth, Volume 7, Issue 10, October 2023., 2023
Abstract Vector‐borne diseases, such as malaria, are affected by the rapid urban growth and climate change in sub‐Saharan Africa (SSA). In this context, intra‐urban malaria risk maps act as a key decision‐making tool for targeting malaria control interventions, especially in resource‐limited settings.
Camille Morlighem, Celia Chaiban, Stefanos Georganos, Oscar Brousse, Nicole P. M. van Lipzig, Eléonore Wolff, Sébastien Dujardin, Catherine Linard   +7 more
wiley   +1 more source